References
- Schwartz B. The Paradox of Choice: Why More Is Less. New York: Ecco Press, an imprint of Harper Collins; 2004.
- Menter A, Strober BE, Kaplan DH, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019 Apr; 80(4):1029–1072.
- Singh JA, Guyatt G, Ogdie A, et al. 2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis. Arthritis Care Res (Hoboken). 2019 Jan;71(1):2–29.
- Gossec L, Baraliakos X, Kerschbaumer A, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis. 2020 Jun; 79(6):S700–S712.
- Coates LC, Corp N, van der Windt DA, et al. GRAPPA treatment recommendations: An update from the 2020 GRAPPA annual meeting. J Rheumatol. 2021 Jun;97:65–66.
- Sbidian E, Chaimani A, Garcia-Doval I, et al. Systemic pharmacological treatments for chronic plaque psoriasis: A network meta‐analysis. Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535.
- Armstrong AW, Puig L, Joshi A, et al. Comparison of biologics and oral treatments for plaque psoriasis: A Meta-analysis. JAMA Dermatol. 2020 Mar 1;156(3):258–269.